Market closed
Tevogen Bio Holdings Inc./$TVGN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tevogen Bio Holdings Inc.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
Ticker
$TVGN
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
18
Website
TVGN Metrics
BasicAdvanced
$180M
-
-$0.07
-0.82
-
Price and volume
Market cap
$180M
Beta
-0.82
52-week high
$1.41
52-week low
$0.89
Average daily volume
495K
Financial strength
Current ratio
0.261
Quick ratio
0.159
Long term debt to equity
-15.07
Total debt to equity
-43.24
Interest coverage (TTM)
-291.05%
Management effectiveness
Return on assets (TTM)
-746.67%
Return on equity (TTM)
27.16%
Valuation
Price to book
-11.27
Price to tangible book (TTM)
-11.27
Price to free cash flow (TTM)
-11.975
Growth
Earnings per share change (TTM)
-97.13%
3-year earnings per share growth (CAGR)
-51.71%
TVGN News
AllArticlesVideos
Tevogen Bio Finalizes Agreement for Company's Own Cell Therapy Production Facility
GlobeNewsWire·2 days ago
Tevogen Bio Commissions Databricks to Accelerate Development of PredicTcell, a Precision AI Tool for Target Prediction
GlobeNewsWire·4 days ago
Tevogen CEO to Join Dialogue on Paths to Liquidity: Strategies for Adapting to a Volatile Market at BioNJ's Fifteenth Annual Bio Partnering Conference with Experts from J.P. Morgan, RSM, and Cantor Fitzgerald
GlobeNewsWire·5 days ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Tevogen Bio Holdings Inc. stock?
Tevogen Bio Holdings Inc. (TVGN) has a market cap of $180M as of April 19, 2025.
What is the P/E ratio for Tevogen Bio Holdings Inc. stock?
The price to earnings (P/E) ratio for Tevogen Bio Holdings Inc. (TVGN) stock is 0 as of April 19, 2025.
Does Tevogen Bio Holdings Inc. stock pay dividends?
No, Tevogen Bio Holdings Inc. (TVGN) stock does not pay dividends to its shareholders as of April 19, 2025.
When is the next Tevogen Bio Holdings Inc. dividend payment date?
Tevogen Bio Holdings Inc. (TVGN) stock does not pay dividends to its shareholders.
What is the beta indicator for Tevogen Bio Holdings Inc.?
Tevogen Bio Holdings Inc. (TVGN) has a beta rating of -0.82. This means that it has an inverse relation to market volatility.